Thanks for hosting me today! It was great to hear about all of the exciting liquid biopsy research happening U-M Rogel Cancer Center, catch up with old friends, and make new friends!

Thanks for hosting me! I enjoyed getting to meet so many outstanding students and faculty. Both the science and miniglof skills at UCSC BME are impressive!

A new study in the JTO from the Thoracic Rad Onc team demonstrates evidence of combined toxicity in patients receiving SABR and VEGF inhibitors. Toxicity is predominately observed in patients with ultra-central tumors.
Link to study: authors.elsevier.com/a/1h41T_ZOPrsI…

Open Faculty Position: Physician Scientist in Radiation Oncology
facultypositions.stanford.edu/en-us/job/4935…

For more on #Liquid Biopsies for Detection and Monitoring, read the Cancer Discovery review by Everett Moding, MD, PhD Barzin Nabet Ash Alizadeh, MD/PhD 🇺🇸 & Max Diehn, MD/PhD: Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease #AACR23 #ctDNA aacrjournals.org/cancerdiscover…

Very excited to share our new study on precursor lesions in follicular lymphoma #FL , out now in Cancer Discovery #lymsm 1/12 🧵
aacrjournals.org/cancerdiscover…

Now in Cancer Discovery: Tracing Founder Mutations in Circulating & Tissue-resident #FollicularLymphoma Precursors by Joe Schroers-Martin, MD Joanne Soo Gabriel Brisou Florian Scherer MD Bertrand Nadel Sandrine Roulland Max Diehn, MD/PhD Ash Alizadeh, MD/PhD 🇺🇸 et al. CIML Stanford Cancer Institute aacrjournals.org/cancerdiscover…

Congratulations David JH Wu, MD, Emily Smith, Eric Hsu, and Justin Jagodinsky! We’re extremely excited that you matched with us and look forward to working with you!

Outstanding insights on new technology in lung cancer 🫁 from NGS in tissue to #liquidbiopsy to the use of AI in pathology by Max Diehn, MD/PhD Geoff Oxnard MD S. Dacic , Phil Mack at #NYLCF23

The LUNGevity Foundation is cultivating future lung cancer scientists through EIGHT PROGRAMS. Apply here: lungevity.org/research/trans…

Susan Hiniker, MD, receives approval from the Children's Oncology Group (Children’s Oncology Group) Scientific Council for the concept summary ARST23P1, 'Catequentinib (Anlotinib) in Combination with Stereotactic Body Radiation Therapy (SBRT) in Children and Young Adults [...]'

Current state of ctDNA based trials in #NSCLC by Max Diehn, MD/PhD

🔺ctDNA MRD is strongly prognostic in early stage #NSCLC BUT we must ⬆️ sensitivity of assays to further personalize adjuvant therapy!
🔺 only 4 active trials testing interventions based on ctDNA.We need more!

#TTLC23

Can an annual blood test find cancer while it’s curable? trib.al/3A2QK7J

Thanks for the kind words Benjamin Rich. It was great fun to meet you, your co-residents, and all the outstanding Sylvester Comprehensive Cancer Center faculty members I got to meet with. Thanks for hosting me!

Very honored to see that #CIBERSORT is among the 5 fastest-growing software tools in the biosciences. Thanks CZI Science for developing this resource and nature for publicizing it. It's been a privilege contributing tools to the scientific community! tinyurl.com/5cemf3pc

Precision radiation medicine coming to #HNCSM 🚗😊

📢Mutant NRF2 confers head & neck cancer radioresistance which can be overcome by NCI CTEP Clinical Research glutaminase inhibitor

Cool study Quynh Thu Le Max Diehn, MD/PhD Stanford Radiation Oncology #radonc #radbio 🙏

OncoAlert

aacrjournals.org/cancerres/arti…

Congrats David!

Hot off the press from our team in collaboration with Max Diehn, MD/PhD Stanford Radiation Oncology:

STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non–Small-Cell Lung Cancer
ascopubs.org/doi/abs/10.120…

Very excited to share our new study on determinants of resistance to anti-CD19 CAR T-cells (CART19) in large B-cell lymphomas (LBCLs)! Out today in Cancer Cell /1

cell.com/cancer-cell/fu…

Excited to share this labor of love from Jurik Mutter Stefan Alig Mohammad Shahrokh Esfahani Max Diehn, MD/PhD and team showcasing the power of #PhasEDSeq #ctDNA #MRD for brain lymphomas: ascopubs.org/doi/full/10.12…